It could therefore be important to investigate a role for GPR1 in Alzheimer’s disease, and it might be of interest to explore whether Aβ42, a proposed ligand for CMKLR1, which is crucially involved in the pathogenesis of Alzheimer’s disease, binds and functions through GPR1. Here, CMKLR2 is linked to early-onset autosomal dominant Alzheimer disease.